Table 1. Inclusion and exclusion criteria as applied during the title/abstract screening to define ‘Tier 1’ articles.

Inclusion Criteria	Exclusion Criteria
Publication between 1975 - 2022 A primary study with a direct comparison of patients undergoing ACLR with LB as an adjunctive to a comparable group not receiving LB Level I evidence only	Absence of study of liposomal bupivacaine in the context of ACLR Retrospective studies, cohort studies, Case series, case reports, expert opinion, or other Level II, III, IV, or V evidence